The impact of dupilumab treatment on SARS-CoV-2/COVID-19 antibody responses in atopic dermatitis patients. Ungar B, Lavin L, Golant AK, Gontzes A, et al. Ann Allergy Asthma Immunol 2022 Mar 25. pii: S1081-1206(22)00210.

Read + Share

Amedeo Smart

Independent Medical Education

Ungar B, Lavin L, Golant AK, Gontzes A, et al. The impact of dupilumab treatment on SARS-CoV-2/COVID-19 antibody responses in atopic dermatitis patients. Ann Allergy Asthma Immunol 2022 Mar 25. pii: S1081-1206(22)00210.
PMID: 35346880